Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 10Prostatic Neoplasms 4Colorectal Neoplasms 4Neoplasm Metastasis 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Obesity-Related Malignant Neoplasm 2Lymphoma 2Hematologic Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Substance-Related Disorders 1Skin Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Opioid-Related Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Healthy Subject 1Genital Neoplasms, Female 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Neoplasms 1

Interventions

pembrolizumab 30Nivolumab 30cabozantinib 20Ipilimumab 15Magnetic Resonance Spectroscopy 14belzutifan 13lenvatinib 11Axitinib 9Specimen Handling 8Sunitinib 7durvalumab 5CTLA-4 Antigen 5tislelizumab 4atezolizumab 4Radiosurgery 4Interleukin-2 4Everolimus 4Biopsy 4Bevacizumab 4pazopanib 3avelumab 3aldesleukin 3Immunoglobulin G 3Disulfides 3palbociclib 2fludarabine 2entinostat 2adavosertib 2Surveys and Questionnaires 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Renal Cell × Educational Status × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡